What Challenges Exist in the Regulation of Nanomedicines?
The regulation of nanomedicines presents several challenges, including the need for standardized methods to characterize nanomaterials, understanding their complex interactions with biological systems, and addressing potential long-term safety concerns. The EMA works closely with international regulatory bodies, academia, and industry to develop harmonized guidelines and advance the science of nanomedicine regulation.
